Intercure Ltd. Ordinary Shares (INCR) is a publicly traded Healthcare sector company. As of May 21, 2026, INCR trades at $0.84 with a market cap of $44.84M and a P/E ratio of -0.47. INCR moved +0.00% today. Year to date, INCR is -17.79%; over the trailing twelve months it is -46.56%. Its 52-week range spans $0.68 to $2.01. Rallies surfaces INCR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Which politicians traded INCR stock?
Rallies tracks politician and congressional stock disclosures for INCR, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
Gaenzle Christopher L sold 4.68K (~$255.43K) on Sep 18, 2017.
Rush Gregory S sold 9.70K (~$528.60K) on Sep 18, 2017.
Macdonald Alistair sold 2.35K (~$128.20K) on Sep 18, 2017.
INCR Analyst Consensus
INCR analyst coverage data. Average price target: $0.00.
Common questions about INCR
Which politicians traded INCR stock?
Rallies tracks politician and congressional stock disclosures for INCR, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
Does Rallies track congressional trades in INCR?
Yes. Rallies tracks politician and congressional stock disclosures for INCR, including reported purchases, sales, dates, owners, and trade amounts when available.
Is INCR research on Rallies investment advice?
No. Rallies provides research, data, and educational context for INCR. It does not provide personalized investment advice.
